PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.68M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-48.13%
Revenue decline while VET shows 11.75% growth. Joel Greenblatt would examine competitive position erosion.
5.86%
Cost growth less than half of VET's 14.49%. David Dodd would verify if cost advantage is structural.
-69.85%
Gross profit decline while VET shows 9.24% growth. Joel Greenblatt would examine competitive position.
-41.87%
Both companies show margin pressure. Martin Whitman would check industry conditions.
No Data
No Data available this quarter, please select a different quarter.
122.44%
G&A growth above 1.5x VET's 12.56%. Michael Burry would check for operational inefficiency.
No Data
No Data available this quarter, please select a different quarter.
-86.67%
Other expenses reduction while VET shows 9307.04% growth. Joel Greenblatt would examine efficiency.
114.83%
Operating expenses growth above 1.5x VET's 9.32%. Michael Burry would check for inefficiency.
42.36%
Total costs growth above 1.5x VET's 12.25%. Michael Burry would check for inefficiency.
1.16%
Interest expense growth above 1.5x VET's 0.73%. Michael Burry would check for over-leverage.
8.33%
D&A growth above 1.5x VET's 1.49%. Michael Burry would check for excessive investment.
-90.23%
EBITDA decline while VET shows 13.40% growth. Joel Greenblatt would examine position.
-87.62%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-116.77%
Operating income decline while VET shows 9.04% growth. Joel Greenblatt would examine position.
-132.32%
Both companies show margin pressure. Martin Whitman would check industry conditions.
54.86%
Other expenses growth while VET reduces costs. John Neff would investigate differences.
-125.95%
Both companies show declining income. Martin Whitman would check industry conditions.
-150.04%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-140.94%
Both companies reducing tax expense. Martin Whitman would check patterns.
-123.79%
Both companies show declining income. Martin Whitman would check industry conditions.
-145.86%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-118.55%
Both companies show declining EPS. Martin Whitman would check industry conditions.
-118.55%
Both companies show declining diluted EPS. Martin Whitman would check industry conditions.
28.12%
Share count change of 28.12% while VET is stable. Bruce Berkowitz would verify approach.
27.89%
Diluted share change of 27.89% while VET is stable. Bruce Berkowitz would verify approach.